Skip to main content

Table 1 Characteristics of patients with MuBC after chemotherapy and surgery

From: Nomogram for predicting survival in patients with mucinous breast cancer undergoing chemotherapy and surgery: a population-based study

Variables

Total queue(SEER)

Training queue

Internal verification queue

External verification queue

 

N = 1668

N = 1169

N = 499

N = 107

 

n

%

n

%

n

%

n

%

Age

        

 ≤ 52

835

50.1

576

49.3

259

51.9

77

72.0

 > 52

833

49.9

593

50.7

240

48.1

30

28.0

Breast subtype

        

 HR+/HER-2−

544

32.6

390

33.4

154

30.9

56

52.3

 HR + /HER2+

178

10.7

126

10.8

52

10.4

10

9.3

 HR-/HER-2+

25

1.5

17

1.5

8

1.6

2

1.9

 HR-/HER-2−

14

0.8

10

0.9

4

0.8

2

1.9

 Unknown

907

54.4

626

53.6

281

56.3

37

34.6

ER status

        

 Negative

104

6.2

72

6.2

32

6.4

9

8.4

 Positive

1564

93.8

1097

93.8

467

93.6

98

91.6

PR status

        

 Negative

332

19.9

225

19.2

107

21.4

16

15.0

 Positive

1336

80.1

944

80.8

392

78.6

91

85.0

HER2 status

        

 Negative

558

33.5

400

34.2

158

31.7

58

54.2

 Positive

203

12.2

143

12.2

60

12.0

12

11.2

 Unknown

907

54.4

626

53.6

281

56.3

37

34.6

Stage

        

 I

540

32.4

382

32.7

158

31.7

30

28.0

 II

836

50.1

590

50.5

246

49.3

53

49.5

 III

268

16.1

179

15.3

89

17.8

22

20.6

 IV

24

1.4

18

1.5

6

1.2

2

1.9

T stage

        

 1

700

42.0

489

41.8

211

42.3

40

37.4

 2

669

40.1

465

39.8

204

40.9

59

55.1

 3

211

12.6

153

13.1

58

11.6

6

5.6

 4

64

3.8

44

3.8

20

4.0

2

1.9

 Unknown

24

1.4

18

1.5

6

1.2

0

0

N stage

        

 0

1049

62.9

741

63.4

308

61.7

66

61.7

 1

458

27.5

325

27.8

133

26.7

23

21.5

 2

101

6.1

59

5.0

42

8.4

8

7.5

 3

60

3.6

44

3.8

16

3.2

10

9.3

M stage

        

 0

1644

98.6

1151

98.5

493

98.8

105

98.1

 1

24

1.4

18

1.5

6

1.2

2

1.9

Historic stage

        

 Localized

1023

61.3

726

62.1

297

59.5

/

/

 Regional

593

35.6

408

34.9

185

37.1

/

/

 Distant

52

3.1

35

3.0

17

3.4

/

/

Surgery

        

 BCS

792

47.5

561

48.0

231

46.3

24

22.4

 Mastectomy

418

25.1

292

25.0

126

25.3

3

2.8

 Radical

458

27.5

316

27.0

142

28.5

80

74.8

Radiotherapy

        

 No

701

42.0

499

42.7

202

40.5

53

49.5

 Yes

967

58.0

670

57.3

297

59.5

54

50.5

Survival

        

 Alive

1423

85.3

1001

85.6

422

84.6

100

93.5

 Dead

245

14.7

168

14.4

77

15.4

7

6.5

  1. HR hormone receptors, HER-2 human epidermal growth factor receptor 2, ER estrogen receptor, PR progesterone receptor, BCS breast-conserving surgery